Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features

Biomaterials
Jörg SchierholzG Pulverer

Abstract

Polymer-associated infections are of increasing importance. Antistaphylococcal antimicrobial substances (ciprofloxacin, gentamycin, fosfomycin, flucloxacillin) were incorporated into polyurethanes by the solvent casting technique. Drug release rates, bacterial colonization and morphological features were evaluated to predict and understand the antimicrobial activity of these delivery systems. Drug release characteristics were investigated by standard bioassay and high-performance liquid chromatography (HPLC), and the physico-chemical mechanisms of the delivery were discussed. Ciprofloxacin hydrochloride showed a fast initial release rate, whereas gentamicin-base was characterized by a more continuous release type of behaviour. Bacterial colonization to the antibiotic-loaded polyurethanes was inhibited effectively by preparations showing a slower but more sustained antimicrobial delivery. Polyurethane-antibiotic combinations were most homogeneous for gentamicin-base and flucloxacillin as shown by scanning electron microscopy (SEM). In polymers loaded with fosfomycin and ciprofloxacin a granular structure of the crystallized drug embedded in the polyurethane matrix could be demonstrated. Physico-chemical similarity of the polymer...Continue Reading

References

May 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·R BaystonS Barsham
Jul 1, 1986·Journal of Vascular Surgery·E G McDougalG Johnson
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·M R Brown, P Williams
Mar 1, 1974·Journal of Pharmaceutical Sciences·Y W ChienD E Grant
Oct 1, 1965·Journal of Pharmaceutical Sciences·S J DesaiW I Higuchi
Jul 1, 1995·The Journal of Hospital Infection·L A SampathS M Modak
Feb 1, 1996·The Journal of Infectious Diseases·I RaadG P Bodey
Jul 1, 1996·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·J M SchierholzG Pulverer

❮ Previous
Next ❯

Citations

Nov 28, 2012·Applied Microbiology and Biotechnology·Nina DiekmannMartina Jahn
Apr 2, 2008·Journal of Industrial Microbiology & Biotechnology·Mari RaulioMirja Salkinoja-Salonen
Jul 19, 2008·Journal of Materials Science. Materials in Medicine·Piyali BasakTapas K Maiti
Nov 16, 2004·Current Urology Reports·Robert Abouassaly, Drogo K Montague
Mar 12, 2005·American Journal of Infection Control·John C CarmenWilliam G Pitt
Dec 4, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·C CastroC Evora
Jul 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cyril DésévauxVincent Lenaerts
Jun 27, 2000·International Journal of Pharmaceutics·J E KimD D Kim
Aug 29, 2006·Chemical Society Reviews·Evan M Hetrick, Mark H Schoenfisch
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Julie A WuJohn F Kokai-Kun
Jul 22, 2004·Journal of Biomaterials Science. Polymer Edition·R BarbucciA Vecchiullo
Jan 18, 2006·Journal of Biomaterials Science. Polymer Edition·Kai KangAnthony Yeung
Jul 12, 2007·Journal of Biomaterials Science. Polymer Edition·Xuemei LiangK Y Simon Ng
Jul 6, 2000·Drugs·K Kanellakopoulou, E J Giamarellos-Bourboulis
Feb 5, 2013·International Journal of Molecular Sciences·Li LiSokol Ndoni
Nov 30, 2013·Biomaterials Science·Scott P Nichols, Mark H Schoenfisch
Dec 4, 2010·Drug Development and Industrial Pharmacy·Chidambaram SoundrapandianSomeswar Datta
Nov 22, 2011·International Journal of Pharmaceutics·Samuel E GilchristHelen M Burt
Nov 11, 1998·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·B RózalskaW Rudnicka
May 19, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·A L DoadrioM Vallet-Regí
Apr 13, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bing LiScott A Guelcher
Mar 12, 2005·Journal of Biomedical Materials Research. Part a·Daniëlle NeutHenk J Busscher
Jun 14, 2003·The Journal of Pharmacy and Pharmacology·Sun-Hee LeeDae-Duk Kim
Nov 10, 2005·Journal of Biomedical Materials Research. Part a·Xuemei LiangK Y Simon Ng
Jun 17, 2006·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Thomas KälickeStephan Arens
Apr 6, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Dustin L WilliamsRoy D Bloebaum
Apr 28, 2004·Biomaterials·J K BavejaL A Poole-Warren
Dec 21, 2005·Biomaterials·Davide CampocciaCarla Renata Arciola
Feb 6, 2014·Journal of Biomedical Materials Research. Part a·Jessica PerkinsSalil Desai
Feb 20, 2014·Advanced Drug Delivery Reviews·Meng-Hua XiongJun Wang
Sep 25, 2001·The Journal of Hospital Infection·J M Schierholz, J Beuth
Apr 22, 2003·Annual Review of Biomedical Engineering·Alan J RussellRichard R Koepsel
Aug 9, 2016·Advanced Drug Delivery Reviews·Danir Fanisovich Bayramov, Jennifer Ann Neff
Oct 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael StengerThomas E Andersen
Apr 14, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Iolanda FrancoliniGianfranco Donelli
Sep 2, 1999·Critical Care Medicine·J M SchierholzZ Wachol-Drebeck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
C S KwokB D Ratner
Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology
Jörg SchierholzG Pulverer
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
I Zimmermann
© 2021 Meta ULC. All rights reserved